neuropilin 1 antagonist (INSERM)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameneuropilin 1 antagonist (INSERM)
Drug Alias NamepTM-NRP1 peptide (INSERM)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNeuropilin-1 inhibitors
TargetsNeuropilin-1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInserm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSATT ConectusInserm
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A